|
Over one million persons are afflicted with bedsores in US hospitals
every year. The problem is growing worse, partly because of an aging population. A radical
departure from present treatment approaches is called for. It is demonstrated that the
cost of bedsores in hospitals is conservatively 55 billion dollars per year. Analysis is
presented concluding that a net savings of 44.5 billion dollars, along with virtual
eradication of the bedsore in hospitals, would result through the widespread preemptive
use of the technology generally acknowledged to be the most effective available. When
patients are hospitalized, they are prone to have skin breakdown wherever the weight of
their body presses into the bed. They are at greatest risk if they move very little or
they are in bed or in a chair for a long time, especially if they also have been losing
weight. Ordinary pressure on the skin as you sit or move across sheets may be enough to
tear or breakdown their skin. It is worth a great deal of effort to keep skin
well-protected; skin breakdown is uncomfortable, a major indignity, and costly.
Phage Therapy
Phage Therapy Center
Phage Therapy Center treats antibiotic-resistant infections. [More information...]
PhageBioderm is designed to treat and prevent infection and maintain appropriate
moisture levels, with maximum mobility and minimum need for materials and time involvement
from therapists.
Tropic Ulcer (Female, 51 yr)
|
|
 |
November
14, 2000 |
|
December 21,
2000 |
|
|
|
May 10,
2001 |
|
|
Tropic Ulcer
|
|
 |
November 22, 2000 |
|
November 22, 2000 |
|
|
 |
February 6, 2001 |
|
April 9, 2001 |
Tropic Ulcer
 |
|
 |
| November 21, 2000 |
|
November 21, 2000 |
 |
|
 |
| December 21, 2000 |
|
January 25, 2001 |
 |
|
|
| March 27, 2001 |
|
|
PhageBioDerm treats tropic
ulcers including Diabetic Ulcers, Panaricium, Infected Superficial Wounds, Bedsores, and
Burns. The treatment effect of this unique remedy is following:
- Protects wound surface from intensive moisture losses due to uncontrollable evaporation,
as well as from external actions like mechanical irritation, microbial invasion, etc.
- Promotes the sanitation of the wound surface and erodes polymeric film thus providing
the sustained release of bioactive substance into surrounding tissues suppressing
pathogenic bacterial flora, resistant to antibiotic and has local painkiller effect.
Additional Information About Phage Therapy for This Condition
Evergreen State College
Bacteriophage Home Phage
Hirzfield Institute of Immunology and Virology
Therapeutic
Use of Bacteriophages in Bacterial Infections
Hirzfield Institute of Immunology and Virology
Efficacy of Phage Therapy - Clinical Trials
Evergreen State College
Polish Update
Alfred's
Story
International Journal of Dermatology
A novel sustained-release matrix based on biodegradable poly(ester
amide)s and impregnated with bacteriophages and an antibiotic shows promise in management
of infected venous stasis ulcers and other poorly healing wounds
The Star Ledger
Germs that Fight Germs
The News Sentinel
Rare cure
saves man's foot
CBS News: 48 Hours
Silent
Killers: Fantastic Phages?
Eliava Institute
List of Bacteriophages
Medical Information
The National Decubitis
Foundation
Decubitus
Ulcers
Presse Med.
Clinical efficacy and cost/benefit ratio of current treatment of MRSA
infections in intensive care units |
